Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer

• Main Authors: Xia H., Hui K.M.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Nature Publishing Group 2020
• Subjects: acetylsalicylic acid; chemokine; clopidogrel; growth arrest and DNA damage inducible protein 45; long chain fatty acid coenzyme A ligase; long chain fatty acid coenzyme A ligase 4; nonsteroid antiinflammatory agent; oxidoreductase; protein HTATIP2; sorafenib; stromal cell derived factor 1 alpha; unclassified drug; antineoplastic agent; antineoplastic activity; bleeding; cancer adjuvant therapy; cancer prevention; cancer recurrence; cancer risk; chronic hepatitis B; chronic liver disease; disease course; disease free survival; drug effect; drug potentiation; gene expression; human; inflammation; liver cell carcinoma; liver fibrosis; liver injury; liver resection; metastasis; metastatic colorectal cancer; nonhuman; Note; overall survival; priority journal; protein expression; randomized controlled trial (topic); risk reduction; thrombocyte; treatment outcome; upregulation; animal; liver tumor; metabolism; pathology; Animals; Antineoplastic Agents; Aspirin; Humans; Liver Neoplasms
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174416
• Institution: National University of Singapore

10.1038/cddis.2017.513